1996
DOI: 10.1007/978-3-642-80053-5_46
|View full text |Cite
|
Sign up to set email alerts
|

When to Start Antifungal Therapy in the Non-Neutropenic Critically III?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1996
1996
2005
2005

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…2 Deep-seated Candida infections are strongly associated with mortality and morbidity of patients, and need early diagnosis and treatment. [3][4][5] Advances in medical technology and anticancer chemotherapies have enabled long-term survival for patients, 6,7 yet increased numbers of deep-seated Candida infections in immunocompromised hosts might become a direct cause of death. 7 …”
Section: Introductionmentioning
confidence: 99%
“…2 Deep-seated Candida infections are strongly associated with mortality and morbidity of patients, and need early diagnosis and treatment. [3][4][5] Advances in medical technology and anticancer chemotherapies have enabled long-term survival for patients, 6,7 yet increased numbers of deep-seated Candida infections in immunocompromised hosts might become a direct cause of death. 7 …”
Section: Introductionmentioning
confidence: 99%